Brief: Adaptive Biotechnologies Reports Fourth Quarter 2022 Results, Provides 2023 Outlook
14/02/2023 21:19
Feb 14 (Reuters) - Adaptive Biotechnologies Q4 EPS USD -0.28 * Q4 net income USD -40.169 million * Outlook FY revenue USD 205-215 million * Q4 revenue USD 55.198 million * Q4 adjusted EBITDA USD -19.6 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates